Efficacy and safety of atezolizumab–bevacizumab vs pembrolizumab-lenvatinib in unresectable hepatocellular carcinoma: a retrospective, cohort study - Hu, Zili; Yang, Zhoutian; Fu, Zibo; Fu, Yizhen; Ma, Zeliang; Zhou, Zhongguo; Chen, Minshan; Zhang, Yaojun (Frontiers in Immunology, 2024)